ATAGI releases Novavax guidance for adolescents The new advice means adolescents aged 12–17 years will have another COVID-19 vaccine option from 5 September.
TGA green lights Nuvaxovid for 12–17-year-olds But while provisional approval has been granted, inclusion in the national program for this age group is yet to be confirmed.
Novavax receives COVID-19 booster approval The protein-based vaccine is the third to gain TGA approval as a booster in Australia, following Pfizer and Moderna.
Novavax approval: what it means for GPs The TGA’s Professor John Skerritt hopes the availability of the new vaccine will push the vaccination rate in Australia even higher.